145 related articles for article (PubMed ID: 9480166)
1. [Evaluation of a noninvasive method for storage control of platelet concentrates].
Schulzki T; Häberle H; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():92-5. PubMed ID: 9480166
[TBL] [Abstract][Full Text] [Related]
2. [Hypotonic shock reaction as quality control marker for platelet concentrates].
Hauswirth WA; Oehler M; Rüther G; Walther-Wenke G
Beitr Infusionsther Transfusionsmed; 1994; 32():88-91. PubMed ID: 9480164
[TBL] [Abstract][Full Text] [Related]
3. Modified CMI, an essential adjunct to CMI of platelet for quality control during preparation and storage of platelet concentrates.
Ray V; Chaudhary R; Singh H
Transfus Apher Sci; 2003 Oct; 29(2):147-9. PubMed ID: 12941353
[TBL] [Abstract][Full Text] [Related]
4. [Preservation of blood platelets concentrates at different temperatures].
León G; Soré A; Linares J; Campo-Aasen I; Carmona O
Acta Cient Venez; 1990; 41(1):43-9. PubMed ID: 2135557
[TBL] [Abstract][Full Text] [Related]
5. [Storage of thrombocyte concentrates: ultrastructural and functional changes].
Böck M; Greither L; Gudden A; Diehm H; Heim MU; Mempel W
Infusionstherapie; 1991 Jun; 18(3):137-8, 141-2. PubMed ID: 1917055
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive pH measurement to monitor changes during suboptimal storage of platelet concentrates.
Krause M; Doescher A; Zimmermann B; Müller TH
Transfusion; 2010 Oct; 50(10):2185-92. PubMed ID: 20456693
[TBL] [Abstract][Full Text] [Related]
7. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
Klein A; Adamik A; Mischke R
Berl Munch Tierarztl Wochenschr; 1999; 112(6-7):243-53. PubMed ID: 10472723
[TBL] [Abstract][Full Text] [Related]
8. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
[TBL] [Abstract][Full Text] [Related]
9. A simple morphological score for the quality control of platelet concentrates.
Mitrović S; Mitrović D; Dragojlović Z; Todorović V; Cuk G; Nedeljković N; Gligorović V
Haematologia (Budap); 1997; 28(4):239-46. PubMed ID: 9408768
[TBL] [Abstract][Full Text] [Related]
10. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
11. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
14. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
[TBL] [Abstract][Full Text] [Related]
15. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.
Mathai J; Resmi KR; Sulochana PV; Sathyabhama S; Baby Saritha G; Krishnan LK
Platelets; 2006 Sep; 17(6):393-6. PubMed ID: 16973500
[TBL] [Abstract][Full Text] [Related]
16. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
17. [Effect of erythrocyte contamination on thrombocyte storage].
Ewertowski R; Kretschmer V; Söhngen D; Biermann E
Beitr Infusionsther; 1990; 26():106-8. PubMed ID: 1703805
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light.
Mohr H; Steil L; Gravemann U; Thiele T; Hammer E; Greinacher A; Müller TH; Völker U
Transfusion; 2009 Dec; 49(12):2612-24. PubMed ID: 19682340
[TBL] [Abstract][Full Text] [Related]
19. L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage.
Deyhim MR; Mesbah-Namin SA; Yari F; Taghikhani M; Amirizadeh N
Ann Hematol; 2015 Apr; 94(4):671-80. PubMed ID: 25399613
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors.
Pérez-Ceballos E; Rivera J; Lozano ML; Candela MJ; Corral J; Guerrero JA; Vicente V
Clin Lab Haematol; 2004 Aug; 26(4):275-86. PubMed ID: 15279665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
